Bristol-Myers Squibb
BMY
#180
Rank
NZ$213.28 B
Marketcap
NZ$104.45
Share price
1.28%
Change (1 day)
33.54%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$6.10

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$6.10. In 2025 the company made an earnings per share (EPS) of NZ$5.93 an increase over its 2024 EPS that were of NZ-$7.58.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.102.93%
2025NZ$5.93-178.28%
2024NZ-$7.58-213.92%
2023NZ$6.6530.2%
2022NZ$5.11-6.04%
2021NZ$5.44-179.29%
2020NZ-$6.86-281.37%
2019NZ$3.78-27.21%
2018NZ$5.19
2016NZ$4.58175.26%
2015NZ$1.66-19.83%
2014NZ$2.07-22.44%
2013NZ$2.6734.48%
2012NZ$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.98 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.03 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.25-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.53-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.38 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.82 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.39-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$16.03 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.10-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.91 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK